Polymorphisms in Genes of Drug Targets and Metabolism and in DNA Repair

摘要: Although we have seen great improvements in both length and quality of life over the last decades, optimal treatment for major diseases such as neurological disorders, coronary artery disease, cancer is not yet a reality. In postgenomic era, new chemotherapeutic drugs are becoming more available, but remaining challenge prospective identification those patients who most likely to benefit from specific medication or drug combination.